BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $234,000 | -15.8% | 4,336 | 0.0% | 0.04% | -10.3% |
| Q2 2022 | $278,000 | -20.6% | 4,336 | -3.9% | 0.04% | -11.4% |
| Q1 2022 | $350,000 | -10.0% | 4,510 | -0.4% | 0.04% | -6.4% |
| Q4 2021 | $389,000 | +6.0% | 4,530 | -0.8% | 0.05% | -6.0% |
| Q3 2021 | $367,000 | -1.3% | 4,565 | -1.2% | 0.05% | -29.6% |
| Q2 2021 | $372,000 | -9.7% | 4,621 | -5.5% | 0.07% | -14.5% |
| Q1 2021 | $412,000 | +8.1% | 4,888 | +2.6% | 0.08% | -6.7% |
| Q4 2020 | $381,000 | -1.0% | 4,763 | -0.6% | 0.09% | -15.2% |
| Q3 2020 | $385,000 | -6.8% | 4,790 | 0.0% | 0.10% | -15.3% |
| Q2 2020 | $413,000 | +4.3% | 4,790 | -2.1% | 0.12% | -13.9% |
| Q1 2020 | $396,000 | -4.3% | 4,893 | -1.7% | 0.14% | +23.1% |
| Q4 2019 | $414,000 | -4.4% | 4,979 | +0.8% | 0.12% | -12.7% |
| Q3 2019 | $433,000 | +5.9% | 4,939 | -1.9% | 0.13% | +13.6% |
| Q2 2019 | $409,000 | -3.8% | 5,035 | -3.9% | 0.12% | -7.1% |
| Q1 2019 | $425,000 | +11.5% | 5,239 | -9.6% | 0.13% | +3.3% |
| Q4 2018 | $381,000 | -5.2% | 5,793 | +11.3% | 0.12% | +6.0% |
| Q3 2018 | $402,000 | +5.2% | 5,206 | -0.2% | 0.12% | -4.9% |
| Q2 2018 | $382,000 | +18.6% | 5,215 | +2.7% | 0.12% | +11.9% |
| Q1 2018 | $322,000 | -8.3% | 5,076 | +1.2% | 0.11% | 0.0% |
| Q4 2017 | $351,000 | +10.4% | 5,018 | -3.2% | 0.11% | -9.2% |
| Q3 2017 | $318,000 | 0.0% | 5,186 | -1.0% | 0.12% | -13.7% |
| Q2 2017 | $318,000 | +14.0% | 5,238 | -0.5% | 0.14% | +4.5% |
| Q1 2017 | $279,000 | +36.8% | 5,266 | +21.6% | 0.13% | +11.8% |
| Q4 2016 | $204,000 | – | 4,331 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |